Breaking News Instant updates and real-time market news.

KL

Kirkland Lake Gold

$45.06 /

+0.065 (+0.14%)

09:23
07/16/20
07/16
09:23
07/16/20
09:23

Kirkland Lake Gold extends suspension of operations at Holt Complex

Kirkland Lake Gold announced that the suspension of operations at the Company's Holt Complex, in effect since April 2, 2020, will be extended until further notice. The Company suspended business activities at the Complex as part of its COVID-19 protocols, and at the same time continued with a strategic review to assess a potential restart of the operations. The Holt Complex, including the Holt, Taylor and Holloway mines and Holt Mill, was designated as non-core by the Company on February 19, 2020 with the Company planning to consider all options to maximize the value of the assets. The Complex's high cost structures, low grades, diminishing reserves and requirements for new investments have resulted in significant negative cash flows from these operations, and are key drivers of our decision to extend the suspension of business activities.

KL Kirkland Lake Gold
$45.06 /

+0.065 (+0.14%)

06/11/20
Fly Intel: Top five analyst upgrades
06/11/20 Roth Capital
Kirkland Lake upgraded to Buy on higher gold prices at Roth Capital
06/11/20 Roth Capital
Kirkland Lake Gold upgraded to Buy from Neutral at Roth Capital
05/29/20 BMO Capital
Kirkland Lake Gold upgraded to Outperform from Market Perform at BMO Capital

TODAY'S FREE FLY STORIES

Downgrade
Mimecast downgraded to Hold from Buy at Summit Insights » 20:01
09/29/20
09/29
20:01
09/29/20
20:01
MSFT

Microsoft

$207.17 /

-2.49 (-1.19%)

, GOOGL

Alphabet Class A

$1,466.78 /

+9.22 (+0.63%)

, MIME

Mimecast

$46.05 /

+0.14 (+0.30%)

Summit Insights analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$207.17 /

-2.49 (-1.19%)

GOOGL Alphabet Class A
$1,466.78 /

+9.22 (+0.63%)

MIME Mimecast
$46.05 /

+0.14 (+0.30%)

MSFT Microsoft
$207.17 /

-2.49 (-1.19%)

06:53 Today Morgan Stanley
RingCentral price target raised to $300 from $280 at Morgan Stanley
09/24/20 Lynx
Microsoft's Bethesda deal positive for AMD, says Lynx
09/24/20 Jefferies
Jefferies 'overwhelmed' by announcements and innovation at Microsoft Ignite
09/23/20 Colliers
Harmonic opportunity in focus after SES partners with Microsoft, says Colliers
GOOGL Alphabet Class A
$1,466.78 /

+9.22 (+0.63%)

09/24/20 Morgan Stanley
Alphabet price target raised to $1,800 after consumer survey at Morgan Stanley
09/18/20 Morgan Stanley
AES Corp. price target raised to $23.50 from $19 at Morgan Stanley
09/15/20
Fly Intel: Top five analyst initiations
09/14/20 KeyBanc
Alphabet initiated with an Overweight at KeyBanc
MIME Mimecast
$46.05 /

+0.14 (+0.30%)

09/09/20 Loop Capital
Mimecast initiated with a Buy at Loop Capital
09/08/20 Loop Capital
Mimecast initiated with a Buy at Loop Capital
08/04/20 JPMorgan
JPMorgan downgrades Mimecast to Underweight on lack of catalysts
08/04/20 Monness Crespi
Mimecast price target raised to $56 from $50 at Monness Crespi
MSFT Microsoft
$207.17 /

-2.49 (-1.19%)

GOOGL Alphabet Class A
$1,466.78 /

+9.22 (+0.63%)

MIME Mimecast
$46.05 /

+0.14 (+0.30%)

MSFT Microsoft
$207.17 /

-2.49 (-1.19%)

GOOGL Alphabet Class A
$1,466.78 /

+9.22 (+0.63%)

MSFT Microsoft
$207.17 /

-2.49 (-1.19%)

GOOGL Alphabet Class A
$1,466.78 /

+9.22 (+0.63%)

MIME Mimecast
$46.05 /

+0.14 (+0.30%)

MSFT Microsoft
$207.17 /

-2.49 (-1.19%)

GOOGL Alphabet Class A
$1,466.78 /

+9.22 (+0.63%)

MSFT Microsoft
$207.17 /

-2.49 (-1.19%)

GOOGL Alphabet Class A
$1,466.78 /

+9.22 (+0.63%)

Upgrade
Spire upgraded to Buy from Hold at Stifel » 19:14
09/29/20
09/29
19:14
09/29/20
19:14
SR

Spire

$52.91 /

+0.04 (+0.08%)

Stifel upgraded Spire to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SR Spire
$52.91 /

+0.04 (+0.08%)

SR Spire
$52.91 /

+0.04 (+0.08%)

09/01/20 Morgan Stanley
Morgan Stanley upgrades Spire to Equal Weight on supportive Missouri legislation
09/01/20 Morgan Stanley
Spire upgraded to Equal Weight from Underweight at Morgan Stanley
08/11/20 Sidoti
Spire upgraded to Buy from Neutral at Sidoti
07/28/20
Fly Intel: Top five analyst upgrades
SR Spire
$52.91 /

+0.04 (+0.08%)

Periodicals
WTO authorizes EU duties on $4B of U.S. goods over Boeing subsidies,Reuters says » 19:11
09/29/20
09/29
19:11
09/29/20
19:11
EADSY

Airbus

$0.00 /

+ (+0.00%)

, BA

Boeing

$163.60 /

-2.48 (-1.49%)

The World Trade…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EADSY Airbus
$0.00 /

+ (+0.00%)

BA Boeing
$163.60 /

-2.48 (-1.49%)

EADSY Airbus
$0.00 /

+ (+0.00%)

09/17/20 Credit Suisse
Airbus price target raised to EUR 106 from EUR 78 at Credit Suisse
09/09/20
Fly Intel: Top five analyst downgrades
09/09/20 Morgan Stanley
Airbus downgraded to Equal Weight from Overweight at Morgan Stanley
08/10/20 JPMorgan
Airbus price target lowered to EUR 50 from EUR 54 at JPMorgan
BA Boeing
$163.60 /

-2.48 (-1.49%)

07:28 Today Morgan Stanley
Morgan Stanley stays Underweight on Boeing despite EASA news
09/28/20
Fly Intel: Top five analyst upgrades
09/28/20 Alembic Global
Alembic upgrades Boeing with 737 MAX return 'finally in sight'
09/28/20 Alembic Global
Boeing upgraded to Overweight from Neutral at Alembic Global
EADSY Airbus
$0.00 /

+ (+0.00%)

BA Boeing
$163.60 /

-2.48 (-1.49%)

EADSY Airbus
$0.00 /

+ (+0.00%)

BA Boeing
$163.60 /

-2.48 (-1.49%)

EADSY Airbus
$0.00 /

+ (+0.00%)

BA Boeing
$163.60 /

-2.48 (-1.49%)

BA Boeing
$163.60 /

-2.48 (-1.49%)

Hot Stocks
GeoVax Labs CEO buys 82K shares, CFO buys 60K shares » 19:09
09/29/20
09/29
19:09
09/29/20
19:09
GOVX

GeoVax Labs

$3.03 /

+0.215 (+7.64%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOVX GeoVax Labs
$3.03 /

+0.215 (+7.64%)

  • 25
    Sep
Hot Stocks
Surgalign to acquire Holo Surgical for up to $125M » 19:05
09/29/20
09/29
19:05
09/29/20
19:05
SRGA

Surgalign

$1.98 /

-0.02 (-1.00%)

Surgalign Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRGA Surgalign
$1.98 /

-0.02 (-1.00%)

SRGA Surgalign
$1.98 /

-0.02 (-1.00%)

SRGA Surgalign
$1.98 /

-0.02 (-1.00%)

Hot Stocks
Eton Pharmaceuticals announces FDA approval of ALKINDI SPRINKLE » 18:51
09/29/20
09/29
18:51
09/29/20
18:51
ETON

Eton Pharmaceuticals

$7.82 /

-0.19 (-2.37%)

Eton Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ETON Eton Pharmaceuticals
$7.82 /

-0.19 (-2.37%)

ETON Eton Pharmaceuticals
$7.82 /

-0.19 (-2.37%)

07/28/20 Lake Street
Eton 'on cusp' of generating significant shareholder value, says Lake Street
05/26/20 H.C. Wainwright
Eton Pharmaceuticals price target lowered to $18 from $26 at H.C. Wainwright
03/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $26 from $23 at H.C. Wainwright
01/28/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $23 from $21 at H.C. Wainwright
ETON Eton Pharmaceuticals
$7.82 /

-0.19 (-2.37%)

ETON Eton Pharmaceuticals
$7.82 /

-0.19 (-2.37%)

Hot Stocks
Newater to be acquired by Crouching Tiger Holding for $3.65 per share » 18:51
09/29/20
09/29
18:51
09/29/20
18:51
NEWA

Newater Technology

$3.55 /

+ (+0.00%)

Newater Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NEWA Newater Technology
$3.55 /

+ (+0.00%)

On The Fly
Fly Intel: After-Hours Movers » 18:47
09/29/20
09/29
18:47
09/29/20
18:47
SNX

Synnex

$132.10 /

+0.6 (+0.46%)

, CMTL

Comtech

$14.05 /

+0.01 (+0.07%)

, CTIC

CTI BioPharma

$1.05 /

+ (+0.00%)

, CVAC

CureVac

$45.55 /

+0.07 (+0.15%)

, CRDF

Cardiff Oncology

$13.98 /

+1.84 (+15.16%)

, MRNA

Moderna

$70.51 /

-0.04 (-0.06%)

, REGN

Regeneron

$573.99 /

+2.38 (+0.42%)

, HEAR

Turtle Beach

$17.29 /

-0.39 (-2.21%)

, PRGS

Progress Software

$38.76 /

+1.47 (+3.94%)

, MU

Micron

$50.71 /

+0.98 (+1.97%)

, LAD

Lithia Motors

$223.07 /

-5.25 (-2.30%)

, FCEL

FuelCell

$2.56 /

+0.13 (+5.35%)

, ARQT

Arcutis Biotherapeutics

$31.05 /

+4.23 (+15.77%)

, OMI

Owens & Minor

$23.52 /

+1.86 (+8.59%)

, CPRX

Catalyst Pharmaceuticals

$3.20 /

+0.04 (+1.27%)

, DIS

Disney

$125.31 /

-0.69 (-0.55%)

Check out this evening's…

ShowHide Related Items >><<
SNX Synnex
$132.10 /

+0.6 (+0.46%)

CMTL Comtech
$14.05 /

+0.01 (+0.07%)

CTIC CTI BioPharma
$1.05 /

+ (+0.00%)

CVAC CureVac
$45.55 /

+0.07 (+0.15%)

CRDF Cardiff Oncology
$13.98 /

+1.84 (+15.16%)

MRNA Moderna
$70.51 /

-0.04 (-0.06%)

REGN Regeneron
$573.99 /

+2.38 (+0.42%)

HEAR Turtle Beach
$17.29 /

-0.39 (-2.21%)

PRGS Progress Software
$38.76 /

+1.47 (+3.94%)

MU Micron
$50.71 /

+0.98 (+1.97%)

LAD Lithia Motors
$223.07 /

-5.25 (-2.30%)

FCEL FuelCell
$2.56 /

+0.13 (+5.35%)

ARQT Arcutis Biotherapeutics
$31.05 /

+4.23 (+15.77%)

OMI Owens & Minor
$23.52 /

+1.86 (+8.59%)

CPRX Catalyst Pharmaceuticals
$3.20 /

+0.04 (+1.27%)

DIS Disney
$125.31 /

-0.69 (-0.55%)

SNX Synnex
$132.10 /

+0.6 (+0.46%)

06/26/20 Barrington
Synnex price target raised to $125 from $115 at Barrington
06/26/20 Loop Capital
Synnex price target raised to $140 from $130 at Loop Capital
06/26/20 Raymond James
Synnex price target raised to $140 from $120 at Raymond James
06/26/20 Citi
Synnex price target raised to $150 from $130 at Citi
CMTL Comtech
$14.05 /

+0.01 (+0.07%)

09/22/20
Fly Intel: Top five analyst downgrades
06/04/20 Northland
Comtech price target lowered to $24 from $27 at Northland
03/31/20 Citi
Comtech price target lowered to $17 from $34 at Citi
CTIC CTI BioPharma
$1.05 /

+ (+0.00%)

06/24/20 JMP Securities
CTI BioPharma resumed with an Outperform at JMP Securities
CVAC CureVac
$45.55 /

+0.07 (+0.15%)

09/08/20 Jefferies
CureVac initiated with a Hold at Jefferies
09/08/20 BofA
CureVac initiated with a Buy at BofA
09/08/20 Credit Suisse
CureVac initiated with a Neutral at Credit Suisse
09/08/20 BofA
CureVac initiated with a Buy at BofA
CRDF Cardiff Oncology
$13.98 /

+1.84 (+15.16%)

09/18/20 Maxim
Cardiff Oncology price target raised to $14 from $6 at Maxim
MRNA Moderna
$70.51 /

-0.04 (-0.06%)

09/18/20 Needham
Moderna shares attractive long term on mRNA platform and pipeline, says Needham
09/17/20 Jefferies
Moderna COVID trial stats suggest late Oct. or Nov. for data, says Jefferies
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/08/20
Fly Intel: Top five analyst downgrades
REGN Regeneron
$573.99 /

+2.38 (+0.42%)

09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/10/20 Benchmark
Vaccine may be approved before Regeneron's COVID therapeutic, says Benchmark
HEAR Turtle Beach
$17.29 /

-0.39 (-2.21%)

16:20 Today Stifel
Turtle Beach initiated with a Buy at Stifel
08/07/20 Maxim
Turtle Beach price target raised to $26 from $20 at Maxim
08/07/20 Lake Street
Turtle Beach price target raised to $24 from $19 at Lake Street
06/23/20 Oppenheimer
Turtle Beach price target raised to $18 from $13 at Oppenheimer
PRGS Progress Software
$38.76 /

+1.47 (+3.94%)

08/26/20 Wedbush
Progress Software assumed with an Outperform at Wedbush
06/26/20 Benchmark
Progress Software price target raised to $43 from $39 at Benchmark
01/17/20 Benchmark
Progress Software price target raised to $57 from $49 at Benchmark
10/22/19 Sidoti
Progress Software initiated with a Buy at Sidoti
MU Micron
$50.71 /

+0.98 (+1.97%)

09/28/20 Citi
Citi opens 'Negative Catalyst Watch' on Micron ahead of results
09/23/20 Cleveland Research
Cleveland Research ups Micron to Buy ahead of expected bottom for DRAM and NAND
09/23/20 Cleveland Research
Micron upgraded to Buy from Neutral at Cleveland Research
09/14/20
Fly Intel: Top five analyst upgrades
LAD Lithia Motors
$223.07 /

-5.25 (-2.30%)

08/28/20 JPMorgan
Lithia Motors price target raised to $280 from $240 at JPMorgan
08/27/20 Benchmark
Benchmark sees more strong earnings from auto dealers, ups targets in group
08/12/20 Guggenheim
Lithia Motors price target raised to $275 from $233 at Guggenheim
07/27/20 Morgan Stanley
Lithia Motors price target raised to $250 from $180 at Morgan Stanley
FCEL FuelCell
$2.56 /

+0.13 (+5.35%)

06/15/20
Fly Intel: Top five analyst downgrades
06/15/20 Craig-Hallum
FuelCell downgraded to Sell at Craig-Hallum
06/12/20 Craig-Hallum
FuelCell downgraded to Sell from Hold at Craig-Hallum
03/16/20 Craig-Hallum
FuelCell upgraded to Hold at Craig-Hallum
ARQT Arcutis Biotherapeutics
$31.05 /

+4.23 (+15.77%)

03/20/20 Cantor Fitzgerald
Arcutis dermatology potential remains underappreciated, says Cantor Fitzgerald
02/25/20 Guggenheim
Guggenheim starts Arcutis Biotherapeutics with Buy, $36 price target
02/25/20 Cantor Fitzgerald
Arcutis Biotherapeutics initiated with an Overweight at Cantor Fitzgerald
02/25/20 Cantor Fitzgerald
Arcutis Biotherapeutics initiated with an Overweight at Cantor Fitzgerald
OMI Owens & Minor
$23.52 /

+1.86 (+8.59%)

09/25/20 Barclays
Owens & Minor upgraded to Equal Weight on manufacturing gains at Barclays
09/25/20 Barclays
Owens & Minor upgraded to Equal Weight from Underweight at Barclays
09/24/20 Baird
Owens & Minor price target raised to $34 from $21 at Baird
08/11/20 Baird
Baird names Owens & Minor as Fresh Pick, sees 'unusual opportunity'
CPRX Catalyst Pharmaceuticals
$3.20 /

+0.04 (+1.27%)

08/11/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $6 from $7 at Piper Sandler
11/13/19 Piper Jaffray
Catalyst Pharmaceuticals price target lowered to $7 from $8 at Piper Jaffray
10/09/19 Piper Jaffray
Catalyst should see limited impact from Ruzurgi launch, says Piper Jaffray
DIS Disney
$125.31 /

-0.69 (-0.55%)

09/28/20 Benchmark
Benchmark says market continues overestimating Netflix's 'sustainable dominance'
09/24/20 Needham
Disney Q4 revenue, earnings outlook lowered at Needham
09/14/20 Jefferies
ESPN deal positive for both Caesars and DraftKings, says Jefferies
09/14/20 Evercore ISI
ESPN deal could add up to material dollars for DraftKings, says Evercore
SNX Synnex
$132.10 /

+0.6 (+0.46%)

CMTL Comtech
$14.05 /

+0.01 (+0.07%)

CTIC CTI BioPharma
$1.05 /

+ (+0.00%)

MRNA Moderna
$70.51 /

-0.04 (-0.06%)

REGN Regeneron
$573.99 /

+2.38 (+0.42%)

HEAR Turtle Beach
$17.29 /

-0.39 (-2.21%)

PRGS Progress Software
$38.76 /

+1.47 (+3.94%)

MU Micron
$50.71 /

+0.98 (+1.97%)

LAD Lithia Motors
$223.07 /

-5.25 (-2.30%)

FCEL FuelCell
$2.56 /

+0.13 (+5.35%)

ARQT Arcutis Biotherapeutics
$31.05 /

+4.23 (+15.77%)

OMI Owens & Minor
$23.52 /

+1.86 (+8.59%)

CPRX Catalyst Pharmaceuticals
$3.20 /

+0.04 (+1.27%)

DIS Disney
$125.31 /

-0.69 (-0.55%)

  • 02
    Oct
  • 02
    Oct
  • 01
    Oct
  • 30
    Sep
  • 30
    Sep
  • 14
    Aug
  • 27
    May
  • 19
    May
  • 12
    Feb
  • 31
    Jan
CMTL Comtech
$14.05 /

+0.01 (+0.07%)

CVAC CureVac
$45.55 /

+0.07 (+0.15%)

MRNA Moderna
$70.51 /

-0.04 (-0.06%)

REGN Regeneron
$573.99 /

+2.38 (+0.42%)

MU Micron
$50.71 /

+0.98 (+1.97%)

OMI Owens & Minor
$23.52 /

+1.86 (+8.59%)

CPRX Catalyst Pharmaceuticals
$3.20 /

+0.04 (+1.27%)

DIS Disney
$125.31 /

-0.69 (-0.55%)

SNX Synnex
$132.10 /

+0.6 (+0.46%)

CMTL Comtech
$14.05 /

+0.01 (+0.07%)

CVAC CureVac
$45.55 /

+0.07 (+0.15%)

MRNA Moderna
$70.51 /

-0.04 (-0.06%)

REGN Regeneron
$573.99 /

+2.38 (+0.42%)

HEAR Turtle Beach
$17.29 /

-0.39 (-2.21%)

PRGS Progress Software
$38.76 /

+1.47 (+3.94%)

MU Micron
$50.71 /

+0.98 (+1.97%)

LAD Lithia Motors
$223.07 /

-5.25 (-2.30%)

FCEL FuelCell
$2.56 /

+0.13 (+5.35%)

ARQT Arcutis Biotherapeutics
$31.05 /

+4.23 (+15.77%)

OMI Owens & Minor
$23.52 /

+1.86 (+8.59%)

DIS Disney
$125.31 /

-0.69 (-0.55%)

SNX Synnex
$132.10 /

+0.6 (+0.46%)

CMTL Comtech
$14.05 /

+0.01 (+0.07%)

CVAC CureVac
$45.55 /

+0.07 (+0.15%)

CRDF Cardiff Oncology
$13.98 /

+1.84 (+15.16%)

MRNA Moderna
$70.51 /

-0.04 (-0.06%)

REGN Regeneron
$573.99 /

+2.38 (+0.42%)

MU Micron
$50.71 /

+0.98 (+1.97%)

FCEL FuelCell
$2.56 /

+0.13 (+5.35%)

OMI Owens & Minor
$23.52 /

+1.86 (+8.59%)

DIS Disney
$125.31 /

-0.69 (-0.55%)

Hot Stocks
McCormick CEO: Consumer segment seeing strong demand » 18:25
09/29/20
09/29
18:25
09/29/20
18:25
MKC

McCormick

$189.86 /

-5.41 (-2.77%)

In an interview on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MKC McCormick
$189.86 /

-5.41 (-2.77%)

MKC McCormick
$189.86 /

-5.41 (-2.77%)

09/24/20 Argus
McCormick initiated with a Buy at Argus
07/15/20 Credit Suisse
McCormick price target raised to $200 from $187 at Credit Suisse
06/26/20 Deutsche Bank
McCormick price target raised to $182 from $156 at Deutsche Bank
06/22/20 Jefferies
McCormick upgraded to Hold on sustainable food-at-home lift at Jefferies
MKC McCormick
$189.86 /

-5.41 (-2.77%)

MKC McCormick
$189.86 /

-5.41 (-2.77%)

MKC McCormick
$189.86 /

-5.41 (-2.77%)

Hot Stocks
Moderna says COVID-19 vaccine candidate analysis published in NEJM » 18:20
09/29/20
09/29
18:20
09/29/20
18:20
MRNA

Moderna

$70.51 /

-0.04 (-0.06%)

Moderna announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$70.51 /

-0.04 (-0.06%)

MRNA Moderna
$70.51 /

-0.04 (-0.06%)

09/18/20 Needham
Moderna shares attractive long term on mRNA platform and pipeline, says Needham
09/17/20 Jefferies
Moderna COVID trial stats suggest late Oct. or Nov. for data, says Jefferies
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/08/20
Fly Intel: Top five analyst downgrades
MRNA Moderna
$70.51 /

-0.04 (-0.06%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$70.51 /

-0.04 (-0.06%)

MRNA Moderna
$70.51 /

-0.04 (-0.06%)

MRNA Moderna
$70.51 /

-0.04 (-0.06%)

Periodicals
General Motors won't close Nikola deal by tomorrow, CNBC reports » 18:13
09/29/20
09/29
18:13
09/29/20
18:13
GM

General Motors

$28.74 /

-0.66 (-2.24%)

, NKLA

Nikola

$17.88 /

-1.39 (-7.21%)

General Motors (GM) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GM General Motors
$28.74 /

-0.66 (-2.24%)

NKLA Nikola
$17.88 /

-1.39 (-7.21%)

GM General Motors
$28.74 /

-0.66 (-2.24%)

09/22/20 Morgan Stanley
Morgan Stanley says 'Battery Day' may be more significant to industry than Tesla
09/17/20 Roth Capital
Roth raises Workhorse target to $33 after Lordstown's 'compelling' analyst day
09/17/20 Deutsche Bank
GM news 'potentially disruptive' to powertrain suppliers, says Deutsche Bank
09/14/20 JPMorgan
Core criticism of Nikola short report 'misconceived,' says JPMorgan
NKLA Nikola
$17.88 /

-1.39 (-7.21%)

09/24/20
Fly Intel: Top five analyst downgrades
09/24/20 Wedbush
Wedbush downgrades Nikola to sell on 'dark cloud,' Tesla innovations
09/23/20 Wedbush
Nikola downgraded to Underperform from Neutral at Wedbush
09/21/20 Deutsche Bank
Deutsche cuts Nikola target to $29 from $50 after possible 'clearing event'
GM General Motors
$28.74 /

-0.66 (-2.24%)

NKLA Nikola
$17.88 /

-1.39 (-7.21%)

GM General Motors
$28.74 /

-0.66 (-2.24%)

NKLA Nikola
$17.88 /

-1.39 (-7.21%)

GM General Motors
$28.74 /

-0.66 (-2.24%)

NKLA Nikola
$17.88 /

-1.39 (-7.21%)

GM General Motors
$28.74 /

-0.66 (-2.24%)

NKLA Nikola
$17.88 /

-1.39 (-7.21%)

Periodicals
Amazon gets into virtual tourism, with Amazon Explore, GeekWire reports » 17:59
09/29/20
09/29
17:59
09/29/20
17:59
AMZN

Amazon.com

$3,144.59 /

-28.48 (-0.90%)

, AIRB

Airbnb

$0.00 /

+ (+0.00%)

, EXPE

Expedia

$91.87 /

-2.49 (-2.64%)

, TRIP

TripAdvisor

$19.57 /

-0.26 (-1.31%)

, BKNG

Booking Holdings

$1,672.89 /

-28.61 (-1.68%)

Ecommerce giant Amazon…

Ecommerce giant Amazon (AMZN) is entering the virtual tourism space with a new service called Amazon Explore, writes GeekWires's Todd Bishop. Amazon's entry into virtual experiences will be tailored to on one-on-one experiences for purchase, primarily by individuals and families," added the GeekWire story, as opposed to a recently announced Airbnb (AIRB) feature called Online Experiences which is "available to small groups of people from different locations," noted GW. Companies that may be impacted include Expedia Group, Inc. (EXPE), TripAdvisor (TRIP) and Booking Holdings (BKNG). Reference Link

ShowHide Related Items >><<
TRIP TripAdvisor
$19.57 /

-0.26 (-1.31%)

EXPE Expedia
$91.87 /

-2.49 (-2.64%)

BKNG Booking Holdings
$1,672.89 /

-28.61 (-1.68%)

AMZN Amazon.com
$3,144.59 /

-28.48 (-0.90%)

AIRB Airbnb
$0.00 /

+ (+0.00%)

AMZN Amazon.com
$3,144.59 /

-28.48 (-0.90%)

09/28/20 Benchmark
Benchmark says market continues overestimating Netflix's 'sustainable dominance'
09/28/20 Baird
Amazon shares remain at 'attractive buying levels,' says Baird
09/24/20 Piper Sandler
Amazon.com assumed with an Overweight at Piper Sandler
09/24/20 Morgan Stanley
Alphabet price target raised to $1,800 after consumer survey at Morgan Stanley
AIRB Airbnb
$0.00 /

+ (+0.00%)

EXPE Expedia
$91.87 /

-2.49 (-2.64%)

09/28/20
Fly Intel: Top five analyst downgrades
09/28/20 RBC Capital
Expedia downgraded to Sector Perform from Outperform at RBC Capital
09/28/20 RBC Capital
Expedia downgraded to Sector Perform from Outperform at RBC Capital
09/24/20 Piper Sandler
Expedia assumed with a Neutral at Piper Sandler
TRIP TripAdvisor
$19.57 /

-0.26 (-1.31%)

08/18/20 DA Davidson
TripAdvisor price target raised to $26 from $23 at DA Davidson
08/10/20 RBC Capital
TripAdvisor price target raised to $24 from $19 at RBC Capital
08/10/20 Stifel
TripAdvisor price target raised to $21 from $15 at Stifel
07/29/20 Jefferies
Booking Holdings price target raised to $1,600 from $1,300 at Jefferies
BKNG Booking Holdings
$1,672.89 /

-28.61 (-1.68%)

09/24/20 Piper Sandler
Booking Holdings assumed with a Neutral at Piper Sandler
09/11/20 UBS
Booking Holdings price target raised to $1,950 from $1,850 at UBS
08/10/20 JMP Securities
Booking Holdings resumed with an Outperform at JMP Securities
08/07/20 Credit Suisse
Booking Holdings price target raised to $2,150 from $2,060 at Credit Suisse
TRIP TripAdvisor
$19.57 /

-0.26 (-1.31%)

EXPE Expedia
$91.87 /

-2.49 (-2.64%)

BKNG Booking Holdings
$1,672.89 /

-28.61 (-1.68%)

AMZN Amazon.com
$3,144.59 /

-28.48 (-0.90%)

TRIP TripAdvisor
$19.57 /

-0.26 (-1.31%)

EXPE Expedia
$91.87 /

-2.49 (-2.64%)

AMZN Amazon.com
$3,144.59 /

-28.48 (-0.90%)

AIRB Airbnb
$0.00 /

+ (+0.00%)

TRIP TripAdvisor
$19.57 /

-0.26 (-1.31%)

EXPE Expedia
$91.87 /

-2.49 (-2.64%)

BKNG Booking Holdings
$1,672.89 /

-28.61 (-1.68%)

AMZN Amazon.com
$3,144.59 /

-28.48 (-0.90%)

AIRB Airbnb
$0.00 /

+ (+0.00%)

TRIP TripAdvisor
$19.57 /

-0.26 (-1.31%)

EXPE Expedia
$91.87 /

-2.49 (-2.64%)

BKNG Booking Holdings
$1,672.89 /

-28.61 (-1.68%)

AMZN Amazon.com
$3,144.59 /

-28.48 (-0.90%)

AMZN Amazon.com
$3,144.59 /

-28.48 (-0.90%)

Hot Stocks
Bionano Genomics announces adoption of Saphyr system in Australia and Slovenia » 17:55
09/29/20
09/29
17:55
09/29/20
17:55
BNGO

Bionano Genomics

$0.60 /

+0.0015 (+0.25%)

Bionano Genomics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BNGO Bionano Genomics
$0.60 /

+0.0015 (+0.25%)

BNGO Bionano Genomics
$0.60 /

+0.0015 (+0.25%)

09/24/20 Ladenburg
Bionano Genomics initiated with a Buy at Ladenburg
04/08/20 Oppenheimer
Oppenheimer bullish on Bionano Genomics, initiates with an Outperform
04/08/20 Oppenheimer
Bionano Genomics initiated with an Outperform at Oppenheimer
BNGO Bionano Genomics
$0.60 /

+0.0015 (+0.25%)

Periodicals
Citi's McGuire meets with banking leaders over likely NYC mayoral run, CNBC says » 17:41
09/29/20
09/29
17:41
09/29/20
17:41
BAC

Bank of America

$23.77 /

-0.32 (-1.33%)

, C

Citi

$42.41 /

-0.94 (-2.17%)

, JPM

JPMorgan

$95.36 /

-0.82 (-0.85%)

, USB

U.S. Bancorp

$35.29 /

+0.03 (+0.09%)

, WFC

Wells Fargo

$23.23 /

-0.59 (-2.48%)

, GS

Goldman Sachs

$196.73 /

-2.44 (-1.23%)

, MS

Morgan Stanley

$47.21 /

-1.18 (-2.44%)

Citigroup (C) vice…

Citigroup (C) vice chairman Ray McGuire has recently spoken with several Wall Street allies in an effort to gain their support for what seems to be a likely run for mayor of New York, CNBC's Brian Schwartz reports, citing people familiar with the matter. McGuire has had lunches and dinners with executives who have ties to the banking, hedge fund, and private equity sectors, Schwartz says, noting that the talks have, at least in part, focused on McGuire eyeing a potential mayoral run and whether these executives will contribute to what would surely by an expensive campaign. Other publicly traded companies in the space include Bank of America (BAC), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC). Reference Link

ShowHide Related Items >><<
WFC Wells Fargo
$23.23 /

-0.59 (-2.48%)

USB U.S. Bancorp
$35.29 /

+0.03 (+0.09%)

MS Morgan Stanley
$47.21 /

-1.18 (-2.44%)

JPM JPMorgan
$95.36 /

-0.82 (-0.85%)

GS Goldman Sachs
$196.73 /

-2.44 (-1.23%)

C Citi
$42.41 /

-0.94 (-2.17%)

BAC Bank of America
$23.77 /

-0.32 (-1.33%)

BAC Bank of America
$23.77 /

-0.32 (-1.33%)

09/03/20 Deutsche Bank
Bank of America upgraded to Buy from Hold at Deutsche Bank
07/09/20 DA Davidson
Bank of America downgraded to Neutral from Buy at DA Davidson
07/08/20
Fly Intel: Top five analyst initiations
07/08/20 Seaport Global
Bank of America initiated with a Neutral at Seaport Global
C Citi
$42.41 /

-0.94 (-2.17%)

09/15/20 Wells Fargo
Citi price target lowered to $66 from $72 at Wells Fargo
09/15/20 Morgan Stanley
Citi's 6% decline more than reflects consent order risk, says Morgan Stanley
09/15/20 Piper Sandler
Citi selloff yesterday on comments, article overdone, says Piper Sandler
08/18/20 Odeon Capital
Citi downgraded to Sell from Hold at Odeon Capital
JPM JPMorgan
$95.36 /

-0.82 (-0.85%)

09/21/20 Wells Fargo
Money laundering headlines creating extra headline risk for banks, says Wells
09/17/20 RBC Capital
JPMorgan price target raised to $110 from $99 at RBC Capital
09/03/20 Deutsche Bank
JPMorgan upgraded to Buy from Hold at Deutsche Bank
07/24/20
Fly Intel: Top five analyst upgrades
USB U.S. Bancorp
$35.29 /

+0.03 (+0.09%)

07/31/20 Wolfe Research
U.S. Bancorp initiated with an Outperform at Wolfe Research
07/29/20 Deutsche Bank
U.S. Bancorp upgraded to Buy with $42 target at Deutsche Bank
07/28/20 Deutsche Bank
U.S. Bancorp upgraded to Buy from Hold at Deutsche Bank
07/02/20 RBC Capital
U.S. Bancorp price target lowered to $42 from $48 at RBC Capital
WFC Wells Fargo
$23.23 /

-0.59 (-2.48%)

09/24/20 Baird
Wells Fargo named 'Bullish Fresh Pick' at Baird
09/14/20 Wolfe Research
Wolfe Research upgrades Wells Fargo on 'very compelling' risk/reward
09/14/20 Wolfe Research
Wells Fargo upgraded to Outperform from Peer Perform at Wolfe Research
09/11/20 UBS
Wells Fargo upgraded to Neutral from Sell at UBS
GS Goldman Sachs
$196.73 /

-2.44 (-1.23%)

09/23/20 UBS
Goldman Sachs upgraded to Buy from Neutral at UBS
08/06/20 Piper Sandler
Now is the time to buy Goldman Sachs, says Piper Sandler
07/20/20 Berenberg
Goldman Sachs price target raised to $200 from $160 at Berenberg
07/16/20 DA Davidson
Goldman Sachs price target raised to $238 from $215 at DA Davidson
MS Morgan Stanley
$47.21 /

-1.18 (-2.44%)

07/20/20 Berenberg
Morgan Stanley price target raised to $45 from $36 at Berenberg
07/17/20 DA Davidson
Morgan Stanley price target raised to $64 from $58 at DA Davidson
07/17/20 Argus
Morgan Stanley price target raised to $60 from $48 at Argus
07/17/20 Barclays
Morgan Stanley price target raised to $60 from $55 at Barclays
WFC Wells Fargo
$23.23 /

-0.59 (-2.48%)

USB U.S. Bancorp
$35.29 /

+0.03 (+0.09%)

MS Morgan Stanley
$47.21 /

-1.18 (-2.44%)

JPM JPMorgan
$95.36 /

-0.82 (-0.85%)

GS Goldman Sachs
$196.73 /

-2.44 (-1.23%)

C Citi
$42.41 /

-0.94 (-2.17%)

BAC Bank of America
$23.77 /

-0.32 (-1.33%)

WFC Wells Fargo
$23.23 /

-0.59 (-2.48%)

USB U.S. Bancorp
$35.29 /

+0.03 (+0.09%)

MS Morgan Stanley
$47.21 /

-1.18 (-2.44%)

JPM JPMorgan
$95.36 /

-0.82 (-0.85%)

GS Goldman Sachs
$196.73 /

-2.44 (-1.23%)

C Citi
$42.41 /

-0.94 (-2.17%)

BAC Bank of America
$23.77 /

-0.32 (-1.33%)

WFC Wells Fargo
$23.23 /

-0.59 (-2.48%)

USB U.S. Bancorp
$35.29 /

+0.03 (+0.09%)

MS Morgan Stanley
$47.21 /

-1.18 (-2.44%)

JPM JPMorgan
$95.36 /

-0.82 (-0.85%)

GS Goldman Sachs
$196.73 /

-2.44 (-1.23%)

C Citi
$42.41 /

-0.94 (-2.17%)

BAC Bank of America
$23.77 /

-0.32 (-1.33%)

WFC Wells Fargo
$23.23 /

-0.59 (-2.48%)

USB U.S. Bancorp
$35.29 /

+0.03 (+0.09%)

MS Morgan Stanley
$47.21 /

-1.18 (-2.44%)

JPM JPMorgan
$95.36 /

-0.82 (-0.85%)

GS Goldman Sachs
$196.73 /

-2.44 (-1.23%)

C Citi
$42.41 /

-0.94 (-2.17%)

BAC Bank of America
$23.77 /

-0.32 (-1.33%)

Hot Stocks
Northrop Grumman awarded maximum $249.3M Navy ordering agreement » 17:38
09/29/20
09/29
17:38
09/29/20
17:38
NOC

Northrop Grumman

$325.07 /

-4.11 (-1.25%)

Northrop Grumman was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NOC Northrop Grumman
$325.07 /

-4.11 (-1.25%)

NOC Northrop Grumman
$325.07 /

-4.11 (-1.25%)

09/08/20 Morgan Stanley
Northrop Grumman initiated with an Overweight at Morgan Stanley
07/31/20 RBC Capital
Northrop Grumman price target raised to $391 from $366 at RBC Capital
07/31/20 Bernstein
Northrop Grumman price target raised to $419 from $405 at Bernstein
05/20/20 RBC Capital
Northrop Grumman initiated with Sector Perform on valuation at RBC Capital
NOC Northrop Grumman
$325.07 /

-4.11 (-1.25%)

NOC Northrop Grumman
$325.07 /

-4.11 (-1.25%)

Periodicals
General Motors won't close Nikola deal by tomorrow, CNBC reports  17:37
09/29/20
09/29
17:37
09/29/20
17:37
GM

General Motors

$28.74 /

-0.66 (-2.24%)

, NKLA

Nikola

$17.88 /

-1.39 (-7.21%)

 
ShowHide Related Items >><<
NKLA Nikola
$17.88 /

-1.39 (-7.21%)

GM General Motors
$28.74 /

-0.66 (-2.24%)

GM General Motors
$28.74 /

-0.66 (-2.24%)

09/22/20 Morgan Stanley
Morgan Stanley says 'Battery Day' may be more significant to industry than Tesla
09/17/20 Roth Capital
Roth raises Workhorse target to $33 after Lordstown's 'compelling' analyst day
09/17/20 Deutsche Bank
GM news 'potentially disruptive' to powertrain suppliers, says Deutsche Bank
09/14/20 JPMorgan
Core criticism of Nikola short report 'misconceived,' says JPMorgan
NKLA Nikola
$17.88 /

-1.39 (-7.21%)

09/24/20
Fly Intel: Top five analyst downgrades
09/24/20 Wedbush
Wedbush downgrades Nikola to sell on 'dark cloud,' Tesla innovations
09/23/20 Wedbush
Nikola downgraded to Underperform from Neutral at Wedbush
09/21/20 Deutsche Bank
Deutsche cuts Nikola target to $29 from $50 after possible 'clearing event'
NKLA Nikola
$17.88 /

-1.39 (-7.21%)

GM General Motors
$28.74 /

-0.66 (-2.24%)

NKLA Nikola
$17.88 /

-1.39 (-7.21%)

GM General Motors
$28.74 /

-0.66 (-2.24%)

NKLA Nikola
$17.88 /

-1.39 (-7.21%)

GM General Motors
$28.74 /

-0.66 (-2.24%)

NKLA Nikola
$17.88 /

-1.39 (-7.21%)

GM General Motors
$28.74 /

-0.66 (-2.24%)

Hot Stocks
Regeneron rises 2.2% after REGN-COV2 antibody cocktail lowers viral levels  17:37
09/29/20
09/29
17:37
09/29/20
17:37
REGN

Regeneron

$573.99 /

+2.38 (+0.42%)

 
ShowHide Related Items >><<
REGN Regeneron
$573.99 /

+2.38 (+0.42%)

REGN Regeneron
$573.99 /

+2.38 (+0.42%)

09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/10/20 Benchmark
Vaccine may be approved before Regeneron's COVID therapeutic, says Benchmark
REGN Regeneron
$573.99 /

+2.38 (+0.42%)

  • 27
    May
REGN Regeneron
$573.99 /

+2.38 (+0.42%)

REGN Regeneron
$573.99 /

+2.38 (+0.42%)

REGN Regeneron
$573.99 /

+2.38 (+0.42%)

Hot Stocks
H-CYTE CEO William Home steps down, Robert Greif succeeds » 17:35
09/29/20
09/29
17:35
09/29/20
17:35
HCYT

H-CYTE

$0.55 /

+ (+0.00%)

H-CYTE announced that…

H-CYTE announced that Robert Greif has been named the company's new CEO. Greif joins H-CYTE with experience in pharmaceutical and biotech businesses. Most recently, he was chief commercial officer and business development leader at Atox Bio, where he built the North American commercial organization in preparation for the launch of an immunomodulator. Greif joins H-CYTE as CEO and president effective immediately. He replaces William Horne, who is stepping down as CEO but will remain on the company's board.

ShowHide Related Items >><<
HCYT H-CYTE
$0.55 /

+ (+0.00%)

Hot Stocks
Agnico Eagle announces exploration joint venture with Newmont » 17:33
09/29/20
09/29
17:33
09/29/20
17:33
AEM

Agnico Eagle

$79.79 /

+1.53 (+1.96%)

, NEM

Newmont

$62.79 /

+0.65 (+1.05%)

Agnico Eagle Mines…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NEM Newmont
$62.79 /

+0.65 (+1.05%)

AEM Agnico Eagle
$79.79 /

+1.53 (+1.96%)

AEM Agnico Eagle
$79.79 /

+1.53 (+1.96%)

09/24/20 Raymond James
Agnico Eagle price target raised to $94 from $82 at Raymond James
07/30/20 Scotiabank
Agnico Eagle upgraded to Outperform with $72 target at Scotiabank
07/30/20 Scotiabank
Agnico Eagle upgraded to Outperform from Sector Perform at Scotiabank
05/01/20 TD Securities
Agnico Eagle price target lowered to C$76 from C$77 at TD Securities
NEM Newmont
$62.79 /

+0.65 (+1.05%)

09/11/20 National Bank
Newmont price target raised to C$125 from C$119 at National Bank
07/20/20 Scotiabank
Yamana downgraded to Sector Perform on valuation at Scotiabank
06/29/20 Citi
Newmont price target lowered to $70 from $74 at Citi
05/18/20 Standpoint Research
Newmont downgraded to Hold from Buy at Standpoint Research
NEM Newmont
$62.79 /

+0.65 (+1.05%)

AEM Agnico Eagle
$79.79 /

+1.53 (+1.96%)

NEM Newmont
$62.79 /

+0.65 (+1.05%)

NEM Newmont
$62.79 /

+0.65 (+1.05%)

AEM Agnico Eagle
$79.79 /

+1.53 (+1.96%)

Periodicals
Grayscale now controls roughly 2.4% of total Bitcoin supply, Cointelegraph says » 17:31
09/29/20
09/29
17:31
09/29/20
17:31
GBTC

Bitcoin Investment Trust

$0.00 /

+ (+0.00%)

, BTC

Bitcoin

$0.00 /

+ (+0.00%)

, BITCOIN

Bitcoin

$0.00 /

+ (+0.00%)

Crypto fund manager…

Crypto fund manager Grayscale Investments has recently increased its assets under management in its Bitcoin Trust (GBTC) by over $180M over the past week, writes Cointelegraph's Turner Wright. Grayscale bought an additional 17,100 Bitcoin (BTC) in the past week, added the story. This means that Grayscale controls 2.4% "of total coin supply - currently at 18,502,381 according to CoinMarketCap - and shows no signs of stopping its buying spree," added the Cointelegraph story. Reference Link

ShowHide Related Items >><<
GBTC Bitcoin Investment Trust
$0.00 /

+ (+0.00%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

GBTC Bitcoin Investment Trust
$0.00 /

+ (+0.00%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

01/23/20 Morgan Stanley
PayPal acceptance gap widens against Amazon, Bitcoin, says Morgan Stanley
BITCOIN Bitcoin
$0.00 /

+ (+0.00%)

GBTC Bitcoin Investment Trust
$0.00 /

+ (+0.00%)

BITCOIN Bitcoin
$0.00 /

+ (+0.00%)

GBTC Bitcoin Investment Trust
$0.00 /

+ (+0.00%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

Conference/Events
Crispr Therapeutics participates in a conference call with Morgan Stanley » 17:25
09/29/20
09/29
17:25
09/29/20
17:25
CRSP

Crispr Therapeutics

$84.98 /

+1.43 (+1.71%)

Australian Lead…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$84.98 /

+1.43 (+1.71%)

CRSP Crispr Therapeutics
$84.98 /

+1.43 (+1.71%)

09/22/20 Piper Sandler
Crispr Therapeutics remains a top pick at Piper Sandler
08/05/20 Citi
Citi reiterates Sell rating on Crispr Therapeutics with $31 price target
07/28/20 Needham
Crispr Therapeutics price target raised to $105 from $84 at Needham
07/28/20 Wells Fargo
Crispr Therapeutics price target raised to $110 from $95 at Wells Fargo
CRSP Crispr Therapeutics
$84.98 /

+1.43 (+1.71%)

  • 01
    Jul
  • 21
    Nov
CRSP Crispr Therapeutics
$84.98 /

+1.43 (+1.71%)

Hot Stocks
Mednax CFO Stephen Farber to depart company effective October 1st » 17:22
09/29/20
09/29
17:22
09/29/20
17:22
MD

Mednax

$16.05 /

-0.12 (-0.74%)

MEDNAX entered into an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MD Mednax
$16.05 /

-0.12 (-0.74%)

MD Mednax
$16.05 /

-0.12 (-0.74%)

06/09/20 Mizuho
Mednax price target raised to $20 from $17 at Mizuho
06/08/20 BMO Capital
Mednax price target raised to $20 from $16 at BMO Capital
05/29/20 Mizuho
Mednax price target lowered to $17 from $19 at Mizuho
05/08/20 Deutsche Bank
Mednax price target lowered to $15 from $24 at Deutsche Bank
MD Mednax
$16.05 /

-0.12 (-0.74%)

Initiation
Zynga started with a Buy rating at MKM Partners » 17:21
09/29/20
09/29
17:21
09/29/20
17:21
ZNGA

Zynga

$9.12 /

+0.05 (+0.55%)

As previously reported,…

As previously reported, MKM Partners analyst Eric Handler initiated coverage of Zynga with a Buy rating and $12 price target. The analyst said he likes Zynga for its leadership position in the mobile games space, the fastest growing segment within the video games industry. The company is well positioned to drive increases in bookings and adjusted EBITDA of 13% and 18%, respectively, between 2020-2023, Handler told investors in a research note. He cited organic growth, integration of the two recent acquisitions, steady margin improvement and ability to remain active with M&A as potential growth factors for the company going forward.

ShowHide Related Items >><<
ZNGA Zynga
$9.12 /

+0.05 (+0.55%)

ZNGA Zynga
$9.12 /

+0.05 (+0.55%)

16:16 Today MKM Partners
Zynga initiated with a Buy at MKM Partners
09/22/20 Jefferies
Microsoft deal for Bethesda underscores value of high-quality IP, says Jefferies
09/21/20 Baird
Bethesda deal 'checks a lot of boxes' for Microsoft, says Baird
08/19/20 Jefferies
Zynga remains Top Pick at Jefferies, sees a path to $13
ZNGA Zynga
$9.12 /

+0.05 (+0.55%)

  • 07
    Aug
ZNGA Zynga
$9.12 /

+0.05 (+0.55%)

ZNGA Zynga
$9.12 /

+0.05 (+0.55%)

ZNGA Zynga
$9.12 /

+0.05 (+0.55%)

General news
Treasury Market Summary » 17:20
09/29/20
09/29
17:20
09/29/20
17:20

Treasury Market Summary:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Guardant Health chairman sells 75K shares of common stock » 17:18
09/29/20
09/29
17:18
09/29/20
17:18
GH

Guardant Health

$111.20 /

+2.28 (+2.09%)

In a regulatory filing,…

In a regulatory filing, Guardant Health disclosed that its president and chairman of the board Amirali Talasaz sold 75K shares of common stock on September 25th in a total transaction size of $8.3M. The holding represents about 2% of his total owned.

ShowHide Related Items >><<
GH Guardant Health
$111.20 /

+2.28 (+2.09%)

GH Guardant Health
$111.20 /

+2.28 (+2.09%)

09/09/20 Morgan Stanley
Guardant Health initiated with an Overweight at Morgan Stanley
08/10/20 Canaccord
Guardion Health Sciences FDA approval landmark event, says Canaccord
06/12/20
Fly Intel: Top five analyst initiations
06/12/20 BTIG
BTIG starts genomic profiling test 'pioneer' Guardant Health at Buy
GH Guardant Health
$111.20 /

+2.28 (+2.09%)

  • 02
    Jun
GH Guardant Health
$111.20 /

+2.28 (+2.09%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.